784
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Management of envenomations during pregnancy

, &
Pages 3-15 | Received 30 Mar 2012, Accepted 13 Dec 2012, Published online: 09 Jan 2013

References

  • Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, . The global burden of snakebite: a literature analysis and modeling based on regional estimates of envenoming and deaths. PLoS Med 2008; 5:e218.
  • Kularatne SA, Kumarasiri PV, Pushpakumara SK, Dissanayaka WP, Ariyasena H, Gawarammana IB, Senanayake N. Routine antibiotic therapy in the management of the local inflammatory swelling in venomous snakebites: results of a placebo-controlled study. Ceylon Med J 2005; 50:151–155.
  • Mendez I, Gutierrez JM, Angulo Y, Calvete JJ, Lomonte B. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp.,Elapidae) and its neutralization by a polyspecific antivenom. Toxicon 2011; 58:558–564.
  • Portas TJ, Montali RJ. Spotted black snake (Pseudechis guttatus) envenomation in a maned wolf (Chrysocyon brachyurus). J Zoo Wildl Med 2007; 38:483–487.
  • Spadacci-Morena DD, de Tomy SC, Sano-Martins IS, Katz SG. The effect of experimental Bothrops jararaca envenomation on pregnant mice. Toxicon 2006; 47:196–207.
  • Sutherland SK, Duncan AW, Tibballs J. Death from a snake bite: associated with the supine hypotensive syndrome of pregnancy. Med J Aust 1982; 2:238–239.
  • Nasu K, Ueda T, Miyakawa I. Intrauterine fetal death caused by pit viper venom poisoning in early pregnancy. Gynecol Obstet Invest 2004; 57:114–116.
  • Pant HP, Poudel R, Dsovza V. Intrauterine death following green tree viper bite presenting as antepartum hemorrhage. Int J Obstet Anesth 2010; 19:102–103.
  • Hanprasertpong J, Hanprasertpong T. Abruptio placentae and fetal death following a Malayan pit viper bite. J Obstet Gynaecol Res 2008; 34:258–261.
  • Zugaib M, de Barros AC, Bittar RE, Burdmann EA, Neme B. Abruptio placentae following snake bite. Am J Obstet Gynecol 1985; 151:754–755.
  • Sarkar S, Bhattacharya P, Paswan A. Snakebite in pregnancy: preliminary study. Br J Anaesth 2008; 101:128–129.
  • James RF. Snake bite in pregnancy. Lancet 1985; 2:731.
  • Seneviratne S, de Silva C, Fonseka M, Pathmeswaran A, Gunatilake S, de Silva H. Envenoming due to snake bite during pregnancy. Trans R Soc Trop Med Hyg 2002; 96:272–274.
  • Dunnihoo DR, Rush BM, Wise RB, Brooks GG, Otterson WN. Snake bite poisoning in pregnancy. A review of the literature. J Reprod Med 1992; 37:653–658.
  • Langley RL. Snakebite during pregnancy: a literature review. Wilderness Environ Med 2010; 21:54–60.
  • LaMonica GE, Seifert SA, Rayburn WF. Rattlesnake bites in pregnant women. J Reprod Med 2010; 55:520–522.
  • Kravitz J, Gerardo CJ. Copperhead snakebite treated with crotalidae polyvalent immune Fab (ovine) antivenom in third trimester pregnancy. Clin Toxicol 2006; 44:353–354.
  • Habib AG, Abubakar SB, Abubakar IS, Larnyang S, Durfa N, Nasidi A, .; EchiTab Study Group (Nigeria & UK). Envenoming after carpet viper (Echis ocellatus) bite during pregnancy: timely use of effective antivenom improves maternal and foetal outcomes.Trop Med Int Health 2008; 13:1172–1175.
  • Duru M, Helvaci M, Peker E, Dolapcioglu K, Kaya E. Reptile bite in pregnancy. Hum Exp Toxicol 2008; 27:931–932.
  • Lurie Y, Bentur Y. Vipera palaestinae bite and serum sickness during pregnancy. J Emerg Med 2010; 38:e67–70.
  • Chen YC, Chen MH, Yang CC, Chen YW, Wang LM, Huang CI. Trimeresurus stejnegeri envenoming during pregnancy. Am J Trop Med Hyg 2007; 77:847–849.
  • Sebe A, Satar S, Acikalin A. Snakebite during pregnancy. Hum Exp Toxicol 2005; 24:341–345.
  • Cheng AC, Currie BJ. Venomous snakebites worldwide with a focus on the Australia-Pacific region: current management and controversies. J Intensive Care Med 2004; 19:259–269.
  • Canale E, Isbister GK, Currie BJ. Investigating pressure bandaging for snakebite in a simulated setting: bandage type, training and the effect of transport. Emerg Med Australas 2009; 21:184–190.
  • Bush SP, Green SM, Laack TA, Hayes WK, Cardwell MD, Tanen DA. Pressure immobilization delays mortality and increases intracompartmental pressure after artificial intramuscular rattlesnake envenomation in a porcine model. Ann Emerg Med 2004; 44:599–604.
  • American College of Medical Toxicology, American Academy of Clinical Toxicology, American Association of Poison Control Centers, European Association of Poison Control Centres and Clinical Toxicologists, International Society on Toxinology, Asia Pacific Association of Medical Toxicology. Pressure immobilization after North American Crotalinae snake envenomation. Clin Toxicol 2011; 49:881–882.
  • Bush SP. Snakebite suction devices don’t remove venom: they just suck. Ann Emerg Med 2004; 43:187–188.
  • Alberts MB, Shalit M, LoGalbo F. Suction for venomous snakebite: a study of “mock venom” extraction in a human model. Ann Emerg Med 2004; 43:181–186.
  • Burgess JL, Dart RC. Snake venom coagulopathy: use and abuse of blood products in the treatment of pit viper envenomation. Ann Emerg Med 1991; 20:795–801.
  • Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002; 347:347–356.
  • Holstege CP, Miller MB, Wermuth M, Furbee B, Curry SC. Crotalid snake envenomation. Crit Care Clin 1997; 13:889–921.
  • Handel CC, Izquierdo LA, Curet LB. Black widow spider (Latrodectus mactans) bite during pregnancy. West J Med 1994; 160:261–262.
  • Scalzone JM, Wells SL. Latrodectus mactans (black widow spider) envenomation: an unusual cause for abdominal pain in pregnancy. Obstet Gynecol 1994; 83:830–831.
  • Sherman RP, Groll JM, Gonzalez DI, Aerts MA. Black widow spider (Latrodectus mactans) envenomation in a term pregnancy. Curr Surg 2000; 57:346–348.
  • Russell FE, Marcus P, Streng JA. Black widow spider envenomation during pregnancy. Report of a case. Toxicon 1979; 17:188–189.
  • Wolfe MD, Myers O, Caravati EM, Rayburn WF, Seifert SA. Black widow spider envenomation in pregnancy. J Matern Fetal Neonatal Med 2011; 24:122–126.
  • Anderson PC. Loxoscelism threatening pregnancy: five cases. Am J Obstet Gynecol 1991; 165:1454–1456.
  • Elghblawi E. Loxoscelism in a pregnant woman. Eur J Dermatol 2009; 19:289.
  • Pauli I, Puka J, Gubert IC, Minozzo JC. The efficacy of antivenom in loxoscelism treatment. Toxicon 2006; 48:123–137.
  • Kroger AT, Atkinson WL, Marcuse EK, Pickering LK,Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1–48.
  • Silveira CM, Caceres VM, Dutra MG, Lopes-Camelo J, Castilla EE. Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies. Bull World Health Organ 1995; 73:605–608.
  • Chan WS, Koren G, Barrera M, Rezvani M, Knittel-Keren D, Nulman I. Neurocognitive development of children following in-utero exposure to labetalol for maternal hypertension: a cohort study using a prospectively collected database. Hypertens Pregnancy 2010; 29:271–283.
  • Weber-Schoendorfer C, Hannemann D, Meister R, Elefant E, Cuppers-Maarschalkerweerd B, Arnon J, . The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 2008; 26:24–30.
  • American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776–789.
  • Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 1992; 21:782–787.
  • Isbister GK, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol 2003; 41:291–300.
  • Bryant SM, Pittman LM. Dapsone use in Loxosceles reclusa envenomation: is there an indication?Am J Emerg Med 2003; 21:89–90.
  • Lyde CB. Pregnancy in patients with Hansen disease. Arch Dermatol 1997; 133:623–627.
  • Langley RL. A review of venomous animal bites and stings in pregnant patients. Wilderness Environ Med 2004; 15:207–215.
  • Leibenson L, Leibenson M, Silberstein T. Antepartum fetal death following a yellow scorpion sting. Arch Gynecol Obstet 2010; 281:247–249.
  • Ben Nasr H, Hammami TS, Sahnoun Z, Rebai T, Bouaziz M, Kassis M, Zeghal KM. Scorpion envenomation symptoms in pregnant women. J Venom Anim Toxins Incl Trop Dis 2007; 13: 94–102.
  • Ismail M, Ellison AC, Tilmisany AK. Teratogenicity in the rat of the venom from the scorpion Androctonus amoreuxi (Aud. & Sav.).Toxicon 1983; 21:177–189.
  • Cruttenden K, Nencioni AL, Bernardi MM, Dorce VA. Reproductive toxic effects of Tityus serrulatus scorpion venom in rats. Reprod Toxicol 2008; 25:497–503.
  • Dorce AL, Bellot RG, Dorce VA, Nencioni AL. Effects of prenatal exposure to Tityus bahiensis scorpion venom on rat offspring development. Reprod Toxicol 2009; 28:365–370.
  • Osman OH, Ismail M, el-Asmar MF, Ibrahim SA. Effect on the rat uterus of the venom from the scorpion Leiurus quinquestriatus. Toxicon 1972; 10:363–366.
  • Marei ZA, Ibrahim SA. Stimulation of rat uterus by venom from the scorpion L. quinquestriatus. Toxicon 1979; 17:251–258.
  • Ismail M, Abd-Elsalam MA, al-Ahaidib MS. Androctonus crassicauda (Olivier), a dangerous and unduly neglected scorpion–I. Pharmacological and clinical studies. Toxicon 1994; 32: 1599–1618.
  • Cappon GD, Cook JC, Hurtt ME. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res B Dev Reprod Toxicol 2003; 68:47–56.
  • Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. Br Med J 2001; 322:266–270.
  • Ofori B, Oraichi D, Blais L, Rey E, Berard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006; 77:268–279.
  • LoVecchio F, McBride C. Scorpion envenomations in young children in central Arizona. J Toxicol Clin Toxicol 2003; 41:937–940.
  • Dittrich K, Power AP, Smith NA. Scorpion sting sydrome - a ten year experience. Ann Saudi Med 1995; 15:148–155.
  • US Food and Drug Administration. Approval letter - Anascorp. 2011; Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM270468.pdf. Accessed 3/17/2012.
  • Boyer LV, Theodorou AA, Berg RA, Mallie J, Chavez-Mendez A, Garcia-Ubbelohde W, .; the Arizona Envenomation Investigators. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med 2009; 360:2090–2098.
  • Bilo BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 8:330–337.
  • Habek D, Cerkez-Habek J, Jalsovec D. Anaphylactic shock in response to wasp sting in pregnancy. Zentralbl Gynakol 2000; 122:393–394.
  • Erasmus C, Blackwood W, Wilson J. Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy. Arch Dis Child 1982; 57:785–787.
  • Rizk DE, Mensah-Brown E, Lukic M. Placental abruption and intrauterine death following an ant sting. Int J Gynaecol Obstet 1998; 63:71–72.
  • Rosenfeld CR, Barton MD, Meschia G. Effects of epinephrine on distribution of blood flow in the pregnant ewe. Am J Obstet Gynecol 1976; 124:156–163.
  • Golden DBK. Insect sting anaphylaxis. Immunol Allergy Clin North Am 2007; 27:261–272.
  • Schwartz HJ, Golden DB, Lockey RF. Venom immunotherapy in the Hymenoptera-allergic pregnant patient. J Allergy Clin Immunol 1990; 85:709–712.
  • Bilo MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 2009; 39:1467–1476.
  • Macrokanis CJ, Hall NL, Mein JK. Irukandji syndrome in northern Western Australia: an emerging health problem. Med J Aust 2004; 181:699–702.
  • Huynh TT, Seymour J, Pereira P, Mulcahy R, Cullen P, Carrette T, Little M. Severity of Irukandji syndrome and nematocyst identification from skin scrapings. Med J Aust 2003; 178:38–41.
  • Williamson JA, Callanan VI, Hartwick RF. Serious envenomation by the Northern Australian box-jellyfish (Chironex fleckeri). Med J Aust 1980; 1:13–16.
  • Boulware DR. A randomized, controlled field trial for the prevention of jellyfish stings with a topical sting inhibitor. J Travel Med 2006; 13:166–171.
  • Townsend C. Marine bitesand stings. In:Evers B, Beauchamp R, Mattox K, Townsend C, eds. Sabiston Texbook of Surgery. 16th ed. Philadelphia: W.B. Saunders; 2001:371.
  • Nomura JT, Sato RL, Ahern RM, Snow JL, Kuwaye TT, Yamamoto LG. A randomized paired comparison trial of cutaneous treatments for acute jellyfish (Carybdea alata) stings. Am J Emerg Med 2002; 20:624–626.
  • Currie BJ. Marine antivenoms. J Toxicol Clin Toxicol 2003; 41: 301–308.
  • Currie BJ, Jacups SP. Prospective study of Chironex fleckeri and other box jellyfish stings in the “Top End” of Australia's Northern Territory. Med J Aust 2005; 183:631–636.
  • Corkeron MA. Magnesium infusion to treat Irukandji syndrome. Med J Aust 2003; 178:411.
  • O’Reilly GM, Isbister GK, Lawrie PM, Treston GT, Currie BJ. Prospective study of jellyfish stings from tropical Australia, including the major box jellyfish Chironex fleckeri. Med J Aust 2001; 175:652–655.
  • ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67–75.
  • Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006; 107:1120–1138.
  • Kazy Z, Puho E, Czeizel AE. Teratogenic potential of vaginal metronidazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123:174–178.
  • Wen SW, Zhou J, Yang Q, Fraser W, Olatunbosun O, Walker M. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. Can Med Assoc J 2008; 179: 1263–1268.
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months –- Advisory Committee on Immunization Practices (ACIP), 2011. Morb Mortal Wkly Rep 2011; 60:1424–1426.
  • Committee ISR. Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press; 2004.
  • Gutierrez JM, Williams D, Fan HW, Warrell DA. Snakebite envenoming from a global perspective: Towards an integrated approach. Toxicon 2010; 56:1223–1235.
  • Gutierrez JM, Lomonte B, Leon G, Rucavado A, Chaves F, Angulo Y. Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr Pharm Des 2007; 13:2935–2950.
  • Norris MC, Grieco W, Arkoosh VA. Does continuous intravenous infusion of low-concentration epinephrine impair uterine blood flow in pregnant ewes?Reg Anesth 1995; 20:206–211.
  • Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5:359–364.
  • Berardi A, Rossi K, Cavalleri F, Simoni A, Aguzzoli L, Masellis G, Ferrari F. Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis. J Perinat Med 2004; 32:375–377.
  • Pirson Y, Van Lierde M, Ghysen J, Squifflet JP, Alexandre GP, van Ypersele de Strihou C. Retardation of fetal growth in patients receiving immunosuppressive therapy. N Engl J Med 1985; 313:328.
  • Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197:585.e1–7; discussion 683–4, e1–7.
  • Schatz M, Zeiger RS, Harden KM, Hoffman CP, Forsythe AB, Chilingar LM, . The safety of inhaled beta-agonist bronchodilators during pregnancy. J Allergy Clin Immunol 1988; 82:686–695.
  • Bailey B. Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women?Birth Defects Res A Clin Mol Teratol 2003; 67:133–140.
  • Cheng AC, Winkel KD. Antivenom efficacy, safety and availability: measuring smoke. Med J Aust 2004; 180:5–6.
  • Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34:557–560.
  • Food and Drug Administration. Thimerosol in vaccines. 2009; Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm070430.htm. Accessed 3/17, 2012.
  • Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A,National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol 2009; 85:137–150.
  • Dahmus MA, Sibai BM. Blunt abdominal trauma: are there any predictive factors for abruptio placentae or maternal-fetal distress?Am J Obstet Gynecol 1993; 169:1054–1059.
  • Dupre AR, Morrison JC, Martin JN Jr, Floyd RC, Blake PG. Clinical application of the Kleihauer-Betke test. J Reprod Med 1993; 38:621–624.
  • Combs CA, Nyberg DA, Mack LA, Smith JR, Benedetti TJ. Expectant management after sonographic diagnosis of placental abruption. Am J Perinatol 1992; 9:170–174.
  • Seifert SA, Boyer LV, Benson BE, Rogers JJ. AAPCC database characterization of native U.S. venomous snake exposures, 2001–2005. Clin Toxicol 2009; 47:327–335.
  • O’Malley GF, Dart RC, Kuffner EF. Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med 1999; 340:657.
  • Keyler DE, Dufek MB, Calvin AD, Bramwell TJ, LeSage MG, Raphael DE, . Reduced nicotine distribution from mother to fetal brain in rats vaccinated against nicotine: time course and influence of nicotine dosing regimen. Biochem Pharmacol 2005; 69:1385–1395.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.